Healthcare: Frustrating Flops, Plus Welcome to the Wrinkle Wars

25:02
 
Share
 

Manage episode 227277326 series 2394758
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.

What Gilead Sciences and Sangamo Therapeutics disappointing data means to investors and why Allergan may face a formidable foe in up-and-comer Evolus. Stocks: GILD, SGMO, AGN, EOLS

1344 episodes available. A new episode about every day averaging 33 mins duration .